An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients.
Regulatory T cells are enriched within CD25(high)CD4(+) leukocytes, however their role in renal transplant recipients with stable function vs. recipients with biopsy-proven chronic allograft dysfunction remains unclear. We therefore studied the number, phenotype, and function of CD25(high)CD4(+) cel...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2008
|
| _version_ | 1797077399656988672 |
|---|---|
| author | Akl, A Jones, N Rogers, N Bakr, M Mostafa, A El Shehawy, E Ghoneim, M Wood, K |
| author_facet | Akl, A Jones, N Rogers, N Bakr, M Mostafa, A El Shehawy, E Ghoneim, M Wood, K |
| author_sort | Akl, A |
| collection | OXFORD |
| description | Regulatory T cells are enriched within CD25(high)CD4(+) leukocytes, however their role in renal transplant recipients with stable function vs. recipients with biopsy-proven chronic allograft dysfunction remains unclear. We therefore studied the number, phenotype, and function of CD25(high)CD4(+) cells in the peripheral blood of 30 renal transplant recipients of living-related grafts, comprising 15 rejection-free recipients with stable graft function (Group A) and 15 with biopsy-proven chronic graft dysfunction (Group B). A higher absolute number of CD25(high)CD4(+) cells were present in the peripheral blood of rejection-free recipients (Group A) vs. those recipients with chronic graft dysfunction (Group B) (P = 0.019); but there was no significant difference with healthy volunteers (P = 0.084). In carboxyfluorescein diacetate succinimidyl ester-mixed leukocyte culture assays, depletion of CD25(high)CD4(+) revealed active regulation in 11 (74%) of 15 rejection-free recipient samples (Group A) in response to donor- but not third party-leukocytes, whereas no regulatory activity was observed in any samples from recipients with chronic graft dysfunction (Group B). In conclusion, these data provide evidence for the presence of an increased number of CD25(high)CD4(+) T cells with donor-specific regulatory activity in the peripheral blood of renal transplant recipients with stable graft function compared with recipients with chronic graft dysfunction. |
| first_indexed | 2024-03-07T00:17:25Z |
| format | Journal article |
| id | oxford-uuid:7b54fcd7-7d3c-4c79-90de-306bcf735ede |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T00:17:25Z |
| publishDate | 2008 |
| record_format | dspace |
| spelling | oxford-uuid:7b54fcd7-7d3c-4c79-90de-306bcf735ede2022-03-26T20:49:53ZAn investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:7b54fcd7-7d3c-4c79-90de-306bcf735edeEnglishSymplectic Elements at Oxford2008Akl, AJones, NRogers, NBakr, MMostafa, AEl Shehawy, EGhoneim, MWood, KRegulatory T cells are enriched within CD25(high)CD4(+) leukocytes, however their role in renal transplant recipients with stable function vs. recipients with biopsy-proven chronic allograft dysfunction remains unclear. We therefore studied the number, phenotype, and function of CD25(high)CD4(+) cells in the peripheral blood of 30 renal transplant recipients of living-related grafts, comprising 15 rejection-free recipients with stable graft function (Group A) and 15 with biopsy-proven chronic graft dysfunction (Group B). A higher absolute number of CD25(high)CD4(+) cells were present in the peripheral blood of rejection-free recipients (Group A) vs. those recipients with chronic graft dysfunction (Group B) (P = 0.019); but there was no significant difference with healthy volunteers (P = 0.084). In carboxyfluorescein diacetate succinimidyl ester-mixed leukocyte culture assays, depletion of CD25(high)CD4(+) revealed active regulation in 11 (74%) of 15 rejection-free recipient samples (Group A) in response to donor- but not third party-leukocytes, whereas no regulatory activity was observed in any samples from recipients with chronic graft dysfunction (Group B). In conclusion, these data provide evidence for the presence of an increased number of CD25(high)CD4(+) T cells with donor-specific regulatory activity in the peripheral blood of renal transplant recipients with stable graft function compared with recipients with chronic graft dysfunction. |
| spellingShingle | Akl, A Jones, N Rogers, N Bakr, M Mostafa, A El Shehawy, E Ghoneim, M Wood, K An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients. |
| title | An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients. |
| title_full | An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients. |
| title_fullStr | An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients. |
| title_full_unstemmed | An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients. |
| title_short | An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients. |
| title_sort | investigation to assess the potential of cd25highcd4 t cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients |
| work_keys_str_mv | AT akla aninvestigationtoassessthepotentialofcd25highcd4tcellstoregulateresponsestodonoralloantigensinclinicallystablerenaltransplantrecipients AT jonesn aninvestigationtoassessthepotentialofcd25highcd4tcellstoregulateresponsestodonoralloantigensinclinicallystablerenaltransplantrecipients AT rogersn aninvestigationtoassessthepotentialofcd25highcd4tcellstoregulateresponsestodonoralloantigensinclinicallystablerenaltransplantrecipients AT bakrm aninvestigationtoassessthepotentialofcd25highcd4tcellstoregulateresponsestodonoralloantigensinclinicallystablerenaltransplantrecipients AT mostafaa aninvestigationtoassessthepotentialofcd25highcd4tcellstoregulateresponsestodonoralloantigensinclinicallystablerenaltransplantrecipients AT elshehawye aninvestigationtoassessthepotentialofcd25highcd4tcellstoregulateresponsestodonoralloantigensinclinicallystablerenaltransplantrecipients AT ghoneimm aninvestigationtoassessthepotentialofcd25highcd4tcellstoregulateresponsestodonoralloantigensinclinicallystablerenaltransplantrecipients AT woodk aninvestigationtoassessthepotentialofcd25highcd4tcellstoregulateresponsestodonoralloantigensinclinicallystablerenaltransplantrecipients AT akla investigationtoassessthepotentialofcd25highcd4tcellstoregulateresponsestodonoralloantigensinclinicallystablerenaltransplantrecipients AT jonesn investigationtoassessthepotentialofcd25highcd4tcellstoregulateresponsestodonoralloantigensinclinicallystablerenaltransplantrecipients AT rogersn investigationtoassessthepotentialofcd25highcd4tcellstoregulateresponsestodonoralloantigensinclinicallystablerenaltransplantrecipients AT bakrm investigationtoassessthepotentialofcd25highcd4tcellstoregulateresponsestodonoralloantigensinclinicallystablerenaltransplantrecipients AT mostafaa investigationtoassessthepotentialofcd25highcd4tcellstoregulateresponsestodonoralloantigensinclinicallystablerenaltransplantrecipients AT elshehawye investigationtoassessthepotentialofcd25highcd4tcellstoregulateresponsestodonoralloantigensinclinicallystablerenaltransplantrecipients AT ghoneimm investigationtoassessthepotentialofcd25highcd4tcellstoregulateresponsestodonoralloantigensinclinicallystablerenaltransplantrecipients AT woodk investigationtoassessthepotentialofcd25highcd4tcellstoregulateresponsestodonoralloantigensinclinicallystablerenaltransplantrecipients |